4 ms·
Really great news for the Biosecurity industry because the mRNA vaccines are far easier to manufacture. Main hurdle now seems to be to freeze dry (“lyophilize”)
by bionhoward 6y ago
Really great news for the Biosecurity industry because the mRNA vaccines are far easier to manufacture. Main hurdle now seems to be to freeze dry (“lyophilize”) them for transport, cuz otherwise you gotta keep em at extremely cold temperatures, which adds a ton of cost (and may not even be doable)
- andrewmunsell 6y agoIsn't the big advantage of the Moderna vaccine over BioNTech that it doesn't have to be stored at -80c? This one should be stable at normal refrigerator temperatures for up to a month and -20c for longer, according to the article. That doesn't seem hard to transport at all
- neuronic 6y agoBioNTech didn't get to perform testing regarding storage and is therefore giving the safe numbers. Might as well be possible to transport and store their vaccine at much friendlier temperatures - but since that isn't verified this risk won't be taken with today's knowledge.